The DOI matches its Crossref record; 349 of the 349 references it cites were found in a registry or an index.
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets
Open accessAbstract
Graphical abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759 · cited 8×
“IL-37 binds IL-18Rα (which is also used by IL-18) and recruits SIGIRR for transducing its inhibitory signal [344].”
InfluentialRING Domain E3 Ubiquitin Ligases
Deshaies, R. J., & Joazeiro, C. A. P. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.101807.093809 · Cited by 2,679
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
The COVID-19 Cytokine Storm; What We Know So Far
Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R., & Salem, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01446 · Cited by 1,622
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Recognizing Sepsis as a Global Health Priority — A WHO Resolution
Reinhart, K., Daniels, R., Kissoon, N., Machado, F. R., Schachter, R. D., & Finfer, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1707170 · Cited by 1,356
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Intracellular Toll-like Receptors
Blasius, A. L., & Beutler, B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.012 · Cited by 1,325
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288 · cited 1×
“interferons causing severe inflammation and tissue damage, including acute lung injury or ALI) plays a crucial role in sepsis, influenza, and severe COVID-19 pathogenesis [16-21].”
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288 · cited 13×
“[80] S. Hussain, C.G. Johnson, J. Sciurba, X. Meng, V.P. Stober, C. Liu, J.M. CyphertDaly, K. Bulek, W. Qian, A. Solis, Y. Sakamachi, C.S. Trempus, J.J. Aloor, K.M. Gowdy, W.M. Foster, J.W. Hollingsworth, R.M. Tighe, X. Li, M.B. Fessler, S. Garantziotis, TLR5 participates in the TLR4 receptor complex and promotes MyD8…”
InfluentialIRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Cario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,246
Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 1×
“mutant, that lacks autophosphorylation site, inhibits phagocytosis of apoptotic cells, but does not inhibit LPS-stimulated TLR signalingmediated NF-κB activation [125,126].”
TRIM family proteins and their emerging roles in innate immunity
Ozato, K., Shin, D.-M., Chang, T.-H., & Morse, H. C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2413 · Cited by 1,120
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition
Gareau, J. R., & Lima, C. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3011 · Cited by 1,105
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
Neutrophil migration in infection and wound repair: going forward in reverse
de Oliveira, S., Rosowski, E. E., & Huttenlocher, A. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.49 · Cited by 1,058
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055 · cited 9×
“Negative regulation of TLR signaling by TAMs has been observed in macrophages and DCs [118].”
InfluentialGalli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S.-I., Honda, K., Ohba, Y., Mak, T. W., et al. (2005) · Nature · doi:10.1038/nature03308 · Cited by 1,039
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria
Zhang, D., Zhang, G., Hayden, M. S., Greenblatt, M. B., Bussey, C., Flavell, R. A., & Ghosh, S. (2004) · Science · doi:10.1126/science.1094351 · Cited by 1,004
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 957 · cited 2×
“The mechanism operates well in microglia (brain macrophages) and astrocytes, and is important for protecting dopaminergic neurons from death [208].”
The immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
IL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
Gilchrist, M., Thorsson, V., Li, B., Rust, A. G., Korb, M., Kennedy, K., Hai, T., Bolouri, H., & Aderem, A. (2006) · Nature · doi:10.1038/nature04768 · Cited by 803
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794
Causes, consequences, and reversal of immune system aging
Montecino-Rodriguez, E., Berent-Maoz, B., & Dorshkind, K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64096 · Cited by 793
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
TRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Vermeulen, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)00002-x · Cited by 751
Is a “Cytokine Storm” Relevant to COVID-19?
Sinha, P., Matthay, M. A., & Calfee, C. S. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.3313 · Cited by 717
Antimicrobial peptides: The ancient arm of the human immune system
Wiesner, J., & Vilcinskas, A. (2010) · Virulence · doi:10.4161/viru.1.5.12983 · Cited by 684
Kumar, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01722 · Cited by 684
Self-citationInhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Shembade, N., Ma, A., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 643
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619 · cited 1×
“The complex clears NF-κB bound to the promoters of pro-inflammatory genes and down-regulates their expression to basal levels [207,208,266].”
Hawn, T. R., Verbon, A., Lettinga, K. D., Zhao, L. P., Li, S. S., Laws, R. J., Skerrett, S. J., Beutler, B., Schroeder, L., Nachman, A., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031220 · Cited by 609
SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling
Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J. E., Stark, G. R., & Li, X. (2003) · Nature Immunology · doi:10.1038/ni968 · Cited by 606
Lemke, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009076 · Cited by 598
Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip
Zhang, G., & Ghosh, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109537200 · Cited by 592
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
Deng, M., Tang, Y., Li, W., Wang, X., Zhang, R., Zhang, X., Zhao, X., Liu, J., Tang, C., Liu, Z., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.016 · Cited by 591
DREAM is a Ca2+-regulated transcriptional repressor
Carrión, A. M., Link, W. A., Ledo, F., Mellström, B., & Naranjo, J. R. (1999) · Nature · doi:10.1038/18044 · Cited by 573
The LIM domain: regulation by association
Bach, I. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00314-7 · Cited by 558
Toll-like receptors activation, signaling, and targeting: an overview
El-Zayat, S. R., Sibaii, H., & Mannaa, F. A. (2019) · Bulletin of the National Research Centre · doi:10.1186/s42269-019-0227-2 · Cited by 556
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J., & Volpe, F. (2000) · Nature Cell Biology · doi:10.1038/35014038 · Cited by 554
A20: linking a complex regulator of ubiquitylation to immunity and human disease
Ma, A., & Malynn, B. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3313 · Cited by 548
Carty, M., Goodbody, R., Schröder, M., Stack, J., Moynagh, P. N., & Bowie, A. G. (2006) · Nature Immunology · doi:10.1038/ni1382 · Cited by 539
UBP43 (USP18) Specifically Removes ISG15 from Conjugated Proteins
Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J., & Zhang, D.-E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109078200 · Cited by 531
TAM Receptor Signaling in Immune Homeostasis
Rothlin, C. V., Carrera-Silva, E. A., Bosurgi, L., & Ghosh, S. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112103 · Cited by 510
MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14
Soloaga, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg273 · Cited by 505
A20 in inflammation and autoimmunity
Catrysse, L., Vereecke, L., Beyaert, R., & van Loo, G. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.005 · Cited by 493
Brint, E. K., Xu, D., Liu, H., Dunne, A., McKenzie, A. N. J., O'Neill, L. A. J., & Liew, F. Y. (2004) · Nature Immunology · doi:10.1038/ni1050 · Cited by 489
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology
Vereecke, L., Beyaert, R., & van Loo, G. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.007 · Cited by 482
Expanding TRAF function: TRAF3 as a tri-faced immune regulator
Häcker, H., Tseng, P.-H., & Karin, M. (2011) · Nature Reviews Immunology · doi:10.1038/nri2998 · Cited by 471
The Epidemiology of Sepsis in Patients With Malignancy
Danai, P. A., Moss, M., Mannino, D. M., & Martin, G. S. (2006) · Chest · doi:10.1378/chest.129.6.1432 · Cited by 464
A Deubiquitinase That Regulates Type I Interferon Production
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O'Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., et al. (2007) · Science · doi:10.1126/science.1145918 · Cited by 452
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
Cui, J., Zhu, L., Xia, X., Wang, H. Y., Legras, X., Hong, J., Ji, J., Shen, P., Zheng, S., Chen, Z. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.040 · Cited by 447
Neutrophils: Cinderella of innate immune system
Kumar, V., & Sharma, A. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.012 · Cited by 444
Self-citationNold-Petry, C. A., Lo, C. Y., Rudloff, I., Elgass, K. D., Li, S., Gantier, M. P., Lotz-Havla, A. S., Gersting, S. W., Cho, S. X., Lao, J. C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3103 · Cited by 439
Hasan, U., Chaffois, C., Gaillard, C., Saulnier, V., Merck, E., Tancredi, S., Guiet, C., Brière, F., Vlach, J., Lebecque, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2942 · Cited by 435
Complement, a target for therapy in inflammatory and degenerative diseases
Morgan, B. P., & Harris, C. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4657 · Cited by 431
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Shirey, K. A., Lai, W., Scott, A. J., Lipsky, M., Mistry, P., Pletneva, L. M., Karp, C. L., McAlees, J., Gioannini, T. L., Weiss, J., et al. (2013) · Nature · doi:10.1038/nature12118 · Cited by 423
Dissecting negative regulation of Toll-like receptor signaling
Kondo, T., Kawai, T., & Akira, S. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.002 · Cited by 419
PDZ Domains: Targeting signalling molecules to sub‐membranous sites
Ponting, C. P., Phillips, C., Davies, K. E., & Blake, D. J. (1997) · BioEssays · doi:10.1002/bies.950190606 · Cited by 415
Yang, Y., Liu, B., Dai, J., Srivastava, P. K., Zammit, D. J., Lefrançois, L., & Li, Z. (2007) · Immunity · doi:10.1016/j.immuni.2006.12.005 · Cited by 410
TLR13 Recognizes Bacterial 23 S rRNA Devoid of Erythromycin Resistance–Forming Modification
Oldenburg, M., Krüger, A., Ferstl, R., Kaufmann, A., Nees, G., Sigmund, A., Bathke, B., Lauterbach, H., Suter, M., Dreher, S., et al. (2012) · Science · doi:10.1126/science.1220363 · Cited by 405
Negative regulation of Toll-like-receptor signaling by IRF-4
Negishi, H., Ohba, Y., Yanai, H., Takaoka, A., Honma, K., Yui, K., Matsuyama, T., Taniguchi, T., & Honda, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508327102 · Cited by 405
CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
Sun, S.-C. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.43 · Cited by 400
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells
Chuang, T.-H., & Ulevitch, R. J. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00289-x · Cited by 397
Jawad, I., Lukšić, I., & Rafnsson, S. B. (2012) · Journal of Global Health · doi:10.7189/jogh.01.010404 · Cited by 389
Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
Chuang, T.-H., & Ulevitch, R. J. (2004) · Nature Immunology · doi:10.1038/ni1066 · Cited by 374
Targeting of TAK1 in inflammatory disorders and cancer
Sakurai, H. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.06.007 · Cited by 373
TIPE2, a Negative Regulator of Innate and Adaptive Immunity that Maintains Immune Homeostasis
Sun, H., Gong, S., Carmody, R. J., Hilliard, A., Li, L., Sun, J., Kong, L., Xu, L., Hilliard, B., Hu, S., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.026 · Cited by 369
Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis
Cao, C., Yu, M., & Chai, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2015-1 · Cited by 354
Boddy, M. N., Howe, K. M., Etkin, L. D., Solomon, E., & Freemont, P. S. (1996) · PubMed · Cited by 348
TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
van der Meer, J. H. M., van der Poll, T., & van ‘t Veer, C. (2014) · Blood · doi:10.1182/blood-2013-09-528752 · Cited by 343
Koblansky, A. A., Jankovic, D., Oh, H., Hieny, S., Sungnak, W., Mathur, R., Hayden, M. S., Akira, S., Sher, A., & Ghosh, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.09.016 · Cited by 342
Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria
Feuillet, V., Medjane, S., Mondor, I., Demaria, O., Pagni, P. P., Galán, J. E., Flavell, R. A., & Alexopoulou, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605200103 · Cited by 336
Schneider, M., Zimmermann, A. G., Roberts, R. A., Zhang, L., Swanson, K. V., Wen, H., Davis, B. K., Allen, I. C., Holl, E. K., Ye, Z., et al. (2012) · Nature Immunology · doi:10.1038/ni.2378 · Cited by 335
Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M., & Yeh, E. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4277 · Cited by 335
Toll-like receptors in the pathogenesis of neuroinflammation
Kumar, V. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.012 · Cited by 331 · cited 2×
“The author has discussed TLRs in different inflammatory diseases and their ligands somewhere else [42,43].”
Self-citationO'Neill, L. A. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.004 · Cited by 330
Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza
London, N. R., Zhu, W., Bozza, F. A., Smith, M. C. P., Greif, D. M., Sorensen, L. K., Chen, L., Kaminoh, Y., Chan, A. C., Passi, S. F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000678 · Cited by 330
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
Ananieva, O., Darragh, J., Johansen, C., Carr, J. M., McIlrath, J., Park, J. M., Wingate, A., Monk, C. E., Toth, R., Santos, S. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1644 · Cited by 326
Tanaka, T., Grusby, M. J., & Kaisho, T. (2007) · Nature Immunology · doi:10.1038/ni1464 · Cited by 325
Xiao, H., Gulen, M. F., Qin, J., Yao, J., Bulek, K., Kish, D., Altuntas, C. Z., Wald, D., Ma, C., Zhou, H., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.012 · Cited by 324
Mayr, F. B. (2010) · JAMA · doi:10.1001/jama.2010.851 · Cited by 322
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 318
Rosenthal, V. D., Maki, D. G., Mehta, Y., Leblebicioglu, H., Memish, Z. A., Al-Mousa, H. H., Balkhy, H., Hu, B., Alvarez-Moreno, C., Medeiros, E. A., et al. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.05.029 · Cited by 310
The mouse kinome: Discovery and comparative genomics of all mouse protein kinases
Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T., & Manning, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306880101 · Cited by 308
Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P., & Busslinger, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06367.x · Cited by 307
Heyninck, K., De Valck, D., Berghe, W. V., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G., & Beyaert, R. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.7.1471 · Cited by 295
Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292
TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.
Cheng, G., & Baltimore, D. (1996) · Genes & Development · doi:10.1101/gad.10.8.963 · Cited by 285
Activating and inhibitory functions of DAP12
Turnbull, I. R., & Colonna, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2014 · Cited by 273
NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK
Xia, X., Cui, J., Wang, H. Y., Zhu, L., Matsueda, S., Wang, Q., Yang, X., Hong, J., Songyang, Z., Chen, Z. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.022 · Cited by 273
François-Newton, V., Magno de Freitas Almeida, G., Payelle-Brogard, B., Monneron, D., Pichard-Garcia, L., Piehler, J., Pellegrini, S., & Uzé, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022200 · Cited by 269
Kim, C., Sano, Y., Todorova, K., Carlson, B. A., Arpa, L., Celada, A., Lawrence, T., Otsu, K., Brissette, J. L., Arthur, J. S. C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1640 · Cited by 265
Human TLR10 is an anti-inflammatory pattern-recognition receptor
Oosting, M., Cheng, S.-C., Bolscher, J. M., Vestering-Stenger, R., Plantinga, T. S., Verschueren, I. C., Arts, P., Garritsen, A., van Eenennaam, H., Sturm, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410293111 · Cited by 260
Shuto, T., Xu, H., Wang, B., Han, J., Kai, H., Gu, X.-X., Murphy, T. F., Lim, D. J., & Li, J.-D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151236098 · Cited by 258
Intestinal inflammation in mice deficient in Tir8 , an inhibitory member of the IL-1 receptor family
Garlanda, C., Riva, F., Polentarutti, N., Buracchi, C., Sironi, M., De Bortoli, M., Muzio, M., Bergottini, R., Scanziani, E., Vecchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308680101 · Cited by 254
Shi, M., Deng, W., Bi, E., Mao, K., Ji, Y., Lin, G., Wu, X., Tao, Z., Li, Z., Cai, X., et al. (2008) · Nature Immunology · doi:10.1038/ni1577 · Cited by 254
An, H., Hou, J., Zhou, J., Zhao, W., Xu, H., Zheng, Y., Yu, Y., Liu, S., & Cao, X. (2008) · Nature Immunology · doi:10.1038/ni.1604 · Cited by 252
Twist mediates suppression of inflammation by type I IFNs and Axl
Sharif, M. N., Šošić, D., Rothlin, C. V., Kelly, E., Lemke, G., Olson, E. N., & Ivashkiv, L. B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051725 · Cited by 251
Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling
Guan, Y., Ranoa, D. R. E., Jiang, S., Mutha, S. K., Li, X., Baudry, J., & Tapping, R. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901888 · Cited by 251
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 249
Sweet, M. J., Leung, B. P., Kang, D., Sogaard, M., Schulz, K., Trajkovic, V., Campbell, C. C., Xu, D., & Liew, F. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6633 · Cited by 248
An, H., Zhao, W., Hou, J., Zhang, Y., Xie, Y., Zheng, Y., Xu, H., Qian, C., Zhou, J., Yu, Y., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.014 · Cited by 245
Honke, N., Shaabani, N., Cadeddu, G., Sorg, U. R., Zhang, D.-E., Trilling, M., Klingel, K., Sauter, M., Kandolf, R., Gailus, N., et al. (2012) · Nature Immunology · doi:10.1038/ni.2169 · Cited by 236
NLRC5 Limits the Activation of Inflammatory Pathways
Benko, S., Magalhaes, J. G., Philpott, D. J., & Girardin, S. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903900 · Cited by 235
Li, S., Neff, C. P., Barber, K., Hong, J., Luo, Y., Azam, T., Palmer, B. E., Fujita, M., Garlanda, C., Mantovani, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424626112 · Cited by 230
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Andersson, U., Ottestad, W., & Tracey, K. J. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00172-4 · Cited by 229
USP18 lack in microglia causes destructive interferonopathy of the mouse brain
Goldmann, T., Zeller, N., Raasch, J., Kierdorf, K., Frenzel, K., Ketscher, L., Basters, A., Staszewski, O., Brendecke, S. M., Spiess, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490791 · Cited by 223 · cited 1×
“USP18 also controls activation of inflammatory pathway in microglial cells of the brain [194].”
Qin, J., Qian, Y., Yao, J., Grace, C., & Li, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501363200 · Cited by 223
Modulation of the Interferon Antiviral Response by the TBK1/IKKi Adaptor Protein TANK
Guo, B., & Cheng, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700017200 · Cited by 223
Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M
Deng, J. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28054 · Cited by 220
Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T., & Tominaga, S.-I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81333-u · Cited by 219
Therapeutic potential of complement modulation
Wagner, E., & Frank, M. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3011 · Cited by 218
Suppression of innate inflammation and immunity by interleukin‐37
Dinarello, C. A., Nold‐Petry, C., Nold, M., Fujita, M., Li, S., Kim, S., & Bufler, P. (2016) · European Journal of Immunology · doi:10.1002/eji.201545828 · Cited by 218
Toll-Like Receptors: Regulators of the Immune Response in the Human Gut
Hug, H., Mohajeri, M., & La Fata, G. (2018) · Nutrients · doi:10.3390/nu10020203 · Cited by 217
Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3
Whitmore, M. M., Iparraguirre, A., Kubelka, L., Weninger, W., Hai, T., & Williams, B. R. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3622 · Cited by 214
NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Karki, R., Man, S. M., Malireddi, R. K. S., Kesavardhana, S., Zhu, Q., Burton, A. R., Sharma, B. R., Qi, X., Pelletier, S., Vogel, P., et al. (2016) · Nature · doi:10.1038/nature20597 · Cited by 213
I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
Rothe, M., Xiong, J., Shu, H. B., Williamson, K., Goddard, A., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8241 · Cited by 212
Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells
Tartey, S., & Takeuchi, O. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2016.1261318 · Cited by 209
Fang, W., Bi, D., Zheng, R., Cai, N., Xu, H., Zhou, R., Lu, J., Wan, M., & Xu, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-01868-0 · Cited by 203
SLIM Is a Nuclear Ubiquitin E3 Ligase that Negatively Regulates STAT Signaling
Tanaka, T., Soriano, M. A., & Grusby, M. J. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.008 · Cited by 200
Yoshida, H., Jono, H., Kai, H., & Li, J.-D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509526200 · Cited by 199
Hoetzenecker, W., Echtenacher, B., Guenova, E., Hoetzenecker, K., Woelbing, F., Brück, J., Teske, A., Valtcheva, N., Fuchs, K., Kneilling, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2557 · Cited by 196
Nuclear receptor 4A (NR4A) family – orphans no more
Safe, S., Jin, U.-H., Morpurgo, B., Abudayyeh, A., Singh, M., & Tjalkens, R. B. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.016 · Cited by 192
Deng, M., Scott, M. J., Loughran, P., Gibson, G., Sodhi, C., Watkins, S., Hackam, D., & Billiar, T. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300496 · Cited by 190
Li, Q., Yan, J., Mao, A.-P., Li, C., Ran, Y., Shu, H.-B., & Wang, Y.-Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110946108 · Cited by 189
Yuk, J.-M., Shin, D.-M., Lee, H.-M., Kim, J.-J., Kim, S.-W., Jin, H. S., Yang, C.-S., Park, K. A., Chanda, D., Kim, D.-K., et al. (2011) · Nature Immunology · doi:10.1038/ni.2064 · Cited by 188
Lee, S. M. Y., Kok, K.-H., Jaume, M., Cheung, T. K. W., Yip, T.-F., Lai, J. C. C., Guan, Y., Webster, R. G., Jin, D.-Y., & Peiris, J. S. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324266111 · Cited by 185
TRAF7 Potentiates MEKK3-induced AP1 and CHOP Activation and Induces Apoptosis
Xu, L.-G., Li, L.-Y., & Shu, H.-B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400063200 · Cited by 183
Thomassen, E., Renshaw, B. R., & Sims, J. E. (1999) · Cytokine · doi:10.1006/cyto.1998.0452 · Cited by 183
Li, S., Zheng, H., Mao, A.-P., Zhong, B., Li, Y., Liu, Y., Gao, Y., Ran, Y., Tien, P., & Shu, H.-B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074971 · Cited by 181
NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB
Jono, H., Lim, J. H., Chen, L.-F., Xu, H., Trompouki, E., Pan, Z. K., Mosialos, G., & Li, J.-D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406638200 · Cited by 179
Honke, N., Shaabani, N., Zhang, D.-E., Hardt, C., & Lang, K. S. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.326 · Cited by 177
The roles of Dok family adapters in immunoreceptor signaling
Mashima, R., Hishida, Y., Tezuka, T., & Yamanashi, Y. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00844.x · Cited by 175
Nakhaei, P., Mesplede, T., Solis, M., Sun, Q., Zhao, T., Yang, L., Chuang, T.-H., Ware, C. F., Lin, R., & Hiscott, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000650 · Cited by 174
HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia
Das, N., Dewan, V., Grace, P. M., Gunn, R. J., Tamura, R., Tzarum, N., Watkins, L. R., Wilson, I. A., & Yin, H. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.076 · Cited by 170
Cellular and molecular regulation of innate inflammatory responses
Liu, J., & Cao, X. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.58 · Cited by 170
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
Barochia, A., Solomon, S., Cui, X., Natanson, C., & Eichacker, P. Q. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.558190 · Cited by 169
Heyninck, K., & Beyaert, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01645-7 · Cited by 169
Bulek, K., Swaidani, S., Qin, J., Lu, Y., Gulen, M. F., Herjan, T., Min, B., Kastelein, R. A., Aronica, M., Kosz-Vnenchak, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802729 · Cited by 168
Human infection by avian influenza A H5N1.
Yuen, K., & Wong, S. S. Y. (2005) · PubMed · Cited by 168
Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T., & Akira, S. (2009) · Nature Immunology · doi:10.1038/ni.1771 · Cited by 168
Hutti, J. E., Turk, B. E., Asara, J. M., Ma, A., Cantley, L. C., & Abbott, D. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01101-07 · Cited by 168
Inflammation: a role for NR4A orphan nuclear receptors?
McMorrow, J. P., & Murphy, E. P. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390688 · Cited by 167
Garlanda, C., Anders, H.-J., & Mantovani, A. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.001 · Cited by 165
Cooperation of TLR12 and TLR11 in the IRF8-Dependent IL-12 Response to Toxoplasma gondii Profilin
Raetz, M. M., Кибардин, А. В., Sturge, C. R., Pifer, R., Li, H., Burstein, E., Ozato, K., Larin, S. S., & Yarovinsky, F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301301 · Cited by 165
Autophagosome–lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL
De Leo, M. G., Staiano, L., Vicinanza, M., Luciani, A., Carissimo, A., Mutarelli, M., Di Campli, A., Polishchuk, E., Di Tullio, G., Morra, V., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3386 · Cited by 165
Liu, L., Ilaria, R. L., Kingsley, P. D., Iwama, A., Etten, R. A. V., Palis, J., & Zhang, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3029 · Cited by 164
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions
Tomasello, E., & Vivier, E. (2005) · European Journal of Immunology · doi:10.1002/eji.200425932 · Cited by 163
BUFLER, P., GAMBONI-ROBERTSON, F., AZAM, T., KIM, S.-H., & DINARELLO, C. A. (2004) · Biochemical Journal · doi:10.1042/bj20040217 · Cited by 162
Characterization of a Second Member of the Sentrin Family of Ubiquitin-like Proteins
Kamitani, T., Kito, K., Nguyen, H. P., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11349 · Cited by 162
IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis
Moretti, S., Bozza, S., Oikonomou, V., Renga, G., Casagrande, A., Iannitti, R. G., Puccetti, M., Garlanda, C., Kim, S., Li, S., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004462 · Cited by 161
Modulation of Toll?interleukin 1 receptor mediated signaling
Li, X., & Qin, J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0622-4 · Cited by 161
Guo, H., König, R., Deng, M., Rieß, M., Mo, J., Zhang, L., Petrucelli, A., Yoh, S. M., Barefoot, B. E., Samo, M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.001 · Cited by 161
S100-alarmin-induced innate immune programming protects newborn infants from sepsis
Ulas, T., Pirr, S., Fehlhaber, B., Bickes, M. S., Loof, T. G., Vogl, T., Mellinger, L., Heinemann, A. S., Burgmann, J., Schöning, J., et al. (2017) · Nature Immunology · doi:10.1038/ni.3745 · Cited by 160
Tibrewal, N., Wu, Y., D’Mello, V., Akakura, R., George, T. C., Varnum, B. C., & Birge, R. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706906200 · Cited by 159
Decque, A., Joffre, O., Magalhaes, J. G., Cossec, J.-C., Blecher-Gonen, R., Lapaquette, P., Silvin, A., Manel, N., Joubert, P.-E., Seeler, J.-S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3342 · Cited by 158
Carty, M., Kearney, J., Shanahan, K. A., Hams, E., Sugisawa, R., Connolly, D. J., Doran, C. G., Muñoz‐Wolf, N., Gürtler, C., Fitzgerald, K. A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.005 · Cited by 155
Pattern Recognition Receptors and Their Role in Innate Immunity: Focus on Microbial Protein Ligands
Areschoug, T., & Gordon, S. (2008) · KARGER eBooks · doi:10.1159/000135685 · Cited by 154
Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice
Tong, Y., Cui, J., Li, Q., Zou, J., Wang, H. Y., & Wang, R. (2012) · Cell Research · doi:10.1038/cr.2012.53 · Cited by 152
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
Patel, S. D., Webster, J. D., Varfolomeev, E. E., Kwon, Y. C., Cheng, J. H., Zhang, J., Dugger, D. L., Wickliffe, K. E., Maltzman, A., Sujatha-Bhaskar, S., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0347-0 · Cited by 152
Pålsson‐McDermott, E. M., Doyle, S., McGettrick, A. F., Hardy, M., Husebye, H., Banahan, K., Gong, M., Golenbock, D. T., Espevik, T., & O'Neill, L. A. J. (2009) · Nature Immunology · doi:10.1038/ni.1727 · Cited by 151
Li, W., Deng, M., Loughran, P., Yang, M., Lin, M., Yang, C., Gao, W., Jin, S., Li, S., Cai, J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00229 · Cited by 151
TLR SIGNALING PATHWAY IN PATIENTS WITH SEPSIS
Salomão, R., Martins, P. S., Brunialti, M. K. C., Fernandes, M. D. L., Martos, L., Mendes, M. E., Gomes, N. E., & Rigato, O. (2008) · Shock · doi:10.1097/shk.0b013e318181af2a · Cited by 148
NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens
Yao, Y., Wang, Y., Chen, F., Huang, Y., Zhu, S., Leng, Q., Wang, H., Shi, Y., & Qian, Y. (2012) · Cell Research · doi:10.1038/cr.2012.56 · Cited by 148
CLP-36 PDZ-LIM Protein Associates with Nonmuscle α-Actinin-1 and α-Actinin-4
Vallenius, T., Luukko, K., & Mäkelä, T. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11100 · Cited by 147
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Exploring the next generation of antibody–drug conjugates
Tsuchikama, K., Anami, Y., Ha, S. Y. Y., & Yamazaki, C. M. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00850-2 · Cited by 659
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Li, X., Wei, S., Niu, S., Ma, X., Li, H., Jing, M., & Zhao, Y. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105389 · Cited by 418
Pattern recognition receptors: function, regulation and therapeutic potential
Chen, R., Zou, J., Chen, J., Zhong, X., Kang, R., & Tang, D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02264-1 · Cited by 301
Metadata
- Authors
- Kumar, V.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 89
- Issue
- Pt B
- Pages
- 107087
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3092068695
- Cited by
- 272
- References
- 349
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.